ISLR and colorectal carcinoma: Inspired by recent advances in AAV-mediated gene therapy in human diseases,23,24 we reasoned that augmenting BMP signaling, via ectopic overexpression of Islr in hepatocytes, a liver cell type shown to contribute to a metastatic niche,25 could potentially ameliorate the progression of CRC hepatic metastasis.